Related Experiment Videos
Clinical approaches to migraine prophylaxis
1The Headache Center of Southern California, Scripps Memorial Hospital-Encintas, USA.
The American Journal of Managed Care
|August 13, 2005
Summary
Chronic migraine develops from frequent episodic attacks and medication overuse. Prophylaxis, using approved or alternative agents, is recommended to prevent chronic migraine, balancing benefits against side effects.
Area of Science:
- Neurology
- Pharmacology
Background:
- Chronic migraine is a significant complication of episodic migraine.
- High attack frequency and overuse of abortive medications are key risk factors for chronification.
Purpose of the Study:
- To review current recommendations and available agents for migraine prophylaxis.
- To highlight the importance of individualized treatment strategies.
Main Methods:
- Review of approved and off-label agents for migraine prophylaxis.
- Discussion of risk factors for migraine chronification.
- Consideration of benefit-risk profiles for preventive treatments.
Main Results:
- Approved prophylactic agents include divalproex, topiramate, propranolol, and timolol.
- Other systemic agents and botulinum toxin injections are also utilized.
- Individualized prophylaxis requires careful consideration of potential adverse effects.
Conclusions:
- Prophylaxis is crucial for patients with frequent episodic migraine to prevent progression to chronic migraine.
- Optimal preventive regimens necessitate a personalized approach, weighing efficacy against tolerability.